140 related articles for article (PubMed ID: 31271405)
1. Insight into the antitumor activity of carbosilane Cu(ii)-metallodendrimers through their interaction with biological membrane models.
Sanz Del Olmo N; Carloni R; Bajo AM; Ortega P; Fattori A; Gómez R; Ottaviani MF; García-Gallego S; Cangiotti M; de la Mata FJ
Nanoscale; 2019 Jul; 11(28):13330-13342. PubMed ID: 31271405
[TBL] [Abstract][Full Text] [Related]
2. Fine-Tuning the Interaction and Therapeutic Effect of Cu(II) Carbosilane Metallodendrimers in Cancer Cells: An
Canonico B; Carloni R; Sanz Del Olmo N; Papa S; Nasoni MG; Fattori A; Cangiotti M; de la Mata FJ; Ottaviani MF; García-Gallego S
Mol Pharm; 2020 Jul; 17(7):2691-2702. PubMed ID: 32484691
[TBL] [Abstract][Full Text] [Related]
3. Elaborated study of Cu(II) carbosilane metallodendrimers bearing substituted iminopyridine moieties as antitumor agents.
Carloni R; Sanz Del Olmo N; Canonico B; Montanari M; Ciacci C; Ambrosi G; de la Mata FJ; Ottaviani MF; García-Gallego S
Eur J Med Chem; 2021 Apr; 215():113292. PubMed ID: 33631696
[TBL] [Abstract][Full Text] [Related]
4. Exploring the Interactions of Ruthenium (II) Carbosilane Metallodendrimers and Precursors with Model Cell Membranes through a Dual Spin-Label Spin-Probe Technique Using EPR.
Carloni R; Sanz Del Olmo N; Ortega P; Fattori A; Gómez R; Ottaviani MF; García-Gallego S; Cangiotti M; de la Mata FJ
Biomolecules; 2019 Sep; 9(10):. PubMed ID: 31569790
[TBL] [Abstract][Full Text] [Related]
5. Carbosilane metallodendrimers based on copper (II) complexes: Synthesis, EPR characterization and anticancer activity.
Sanz Del Olmo N; Maroto-Díaz M; Gómez R; Ortega P; Cangiotti M; Ottaviani MF; de la Mata FJ
J Inorg Biochem; 2017 Dec; 177():211-218. PubMed ID: 29031179
[TBL] [Abstract][Full Text] [Related]
6. Cyclopentadienyl ruthenium(II) carbosilane metallodendrimers as a promising treatment against advanced prostate cancer.
Sanz Del Olmo N; Bajo AM; Ionov M; García-Gallego S; Bryszewska M; Gómez R; Ortega P; de la Mata FJ
Eur J Med Chem; 2020 Aug; 199():112414. PubMed ID: 32438200
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial Effect of Carbosilane Metallodendrimers in Planktonic Cells of Gram-Positive and Gram-Negative Bacteria and
Llamazares C; Sanz Del Olmo N; Ortega P; Gómez R; Soliveri J; de la Mata FJ; García-Gallego S; Copa-Patiño JL
Biomolecules; 2019 Aug; 9(9):. PubMed ID: 31450779
[TBL] [Abstract][Full Text] [Related]
8. Antiviral properties against HIV of water soluble copper carbosilane dendrimers and their EPR characterization.
Galan M; Sanchez-Rodriguez J; Cangiotti M; Garcia-Gallego S; Jimenez JL; Gomez R; Ottaviani MF; Munoz-Fernandez MA; de la Mata FJ
Curr Med Chem; 2012; 19(29):4984-94. PubMed ID: 22963631
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Anticancer Properties of Copper Metallodendrimers.
Hołota M; Magiera J; Michlewska S; Kubczak M; Del Olmo NS; García-Gallego S; Ortega P; de la Mata FJ; Ionov M; Bryszewska M
Biomolecules; 2019 Apr; 9(4):. PubMed ID: 31003561
[TBL] [Abstract][Full Text] [Related]
10. Combination of Copper Metallodendrimers with Conventional Antitumor Drugs to Combat Cancer in In Vitro Models.
Hołota M; Michlewska S; Garcia-Gallego S; Del Olmo NS; Ortega P; Bryszewska M; de la Mata FJ; Ionov M
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835489
[TBL] [Abstract][Full Text] [Related]
11. Novel Water-Soluble Mucoadhesive Carbosilane Dendrimers for Ocular Administration.
Bravo-Osuna I; Vicario-de-la-Torre M; Andrés-Guerrero V; Sánchez-Nieves J; Guzmán-Navarro M; de la Mata FJ; Gómez R; de Las Heras B; Argüeso P; Ponchel G; Herrero-Vanrell R; Molina-Martínez IT
Mol Pharm; 2016 Sep; 13(9):2966-76. PubMed ID: 27149661
[TBL] [Abstract][Full Text] [Related]
12. Heterofunctional ruthenium(II) carbosilane dendrons, a new class of dendritic molecules to fight against prostate cancer.
Sanz Del Olmo N; Maroto-Diaz M; Quintana S; Gómez R; Holota M; Ionov M; Bryszewska M; Carmena MJ; Ortega P; Javier de la Mata F
Eur J Med Chem; 2020 Dec; 207():112695. PubMed ID: 32882608
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a fluorescent 1,8-naphthalimide-functionalized PAMAM dendrimer and its Cu(ii) complexes as cytotoxic drugs: EPR and biological studies in myeloid tumor cells.
Canonico B; Cangiotti M; Montanari M; Papa S; Fusi V; Giorgi L; Ciacci C; Ottaviani MF; Staneva D; Grabchev I
Biol Chem; 2022 Feb; 403(3):345-360. PubMed ID: 34883001
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Characterization of FITC Labelled Ruthenium Dendrimer as a Prospective Anticancer Drug.
Michlewska S; Kubczak M; Maroto-Díaz M; Sanz Del Olmo N; Ortega P; Shcharbin D; Gomez Ramirez R; Javier de la Mata F; Ionov M; Bryszewska M
Biomolecules; 2019 Aug; 9(9):. PubMed ID: 31450702
[TBL] [Abstract][Full Text] [Related]
15. Copper (II) Metallodendrimers Combined with Pro-Apoptotic siRNAs as a Promising Strategy Against Breast Cancer Cells.
Sanz Del Olmo N; Holota M; Michlewska S; Gómez R; Ortega P; Ionov M; de la Mata FJ; Bryszewska M
Pharmaceutics; 2020 Aug; 12(8):. PubMed ID: 32748821
[TBL] [Abstract][Full Text] [Related]
16. Glucose-modified carbosilane dendrimers: Interaction with model membranes and human serum albumin.
Wrobel D; Müllerová M; Strašák T; Růžička K; Fulem M; Kubíková R; Bryszewska M; Klajnert-Maculewicz B; Malý J
Int J Pharm; 2020 Apr; 579():119138. PubMed ID: 32061725
[TBL] [Abstract][Full Text] [Related]
17. Use of Half-Generation PAMAM Dendrimers (G0.5-G3.5) with Carboxylate End-Groups to Improve the DACHPtCl
Camacho C; Tomás H; Rodrigues J
Molecules; 2021 May; 26(10):. PubMed ID: 34069054
[TBL] [Abstract][Full Text] [Related]
18. Coordination behavior of tetraaza [N₄] ligand towards Co(II), Ni(II), Cu(II), Cu(I) and Pd(II) complexes: synthesis, spectroscopic characterization and anticancer activity.
El-Boraey HA
Spectrochim Acta A Mol Biomol Spectrosc; 2012 Nov; 97():255-62. PubMed ID: 22765944
[TBL] [Abstract][Full Text] [Related]
19. EPR Characterization of Copper(II) Complexes of PAMAM-Py Dendrimers for Biocatalysis in the Absence and Presence of Reducing Agents and a Spin Trap.
Tang YH; Cangiotti M; Kao CL; Ottaviani MF
J Phys Chem B; 2017 Nov; 121(46):10498-10507. PubMed ID: 29091451
[TBL] [Abstract][Full Text] [Related]
20. Original multivalent copper(II)-conjugated phosphorus dendrimers and corresponding mononuclear copper(II) complexes with antitumoral activities.
El Brahmi N; El Kazzouli S; Mignani SM; Essassi el M; Aubert G; Laurent R; Caminade AM; Bousmina MM; Cresteil T; Majoral JP
Mol Pharm; 2013 Apr; 10(4):1459-64. PubMed ID: 23410260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
